PCN26 A COST-EFFECTIVENESS ANALYSIS OF XELOX AND FOLFOX-4 COMBINED WITH OR WITHOUT BEVACIZUMAB FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN SPAIN
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66563-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66563-1/fulltext
Section Title :
Section Order :
398
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66563-1&doi=10.1016/S1098-3015(10)66563-1